5-MAPDB

5-MAPDB (5-Methylaminopentylbenzodioxolylbutanamine) is a synthetic compound that belongs to the class of phenethylamines. It is structurally related to other compounds such as MDMA and is known for its psychoactive properties. 5-MAPDB is often studied in the context of its effects on the central nervous system and its potential use in psychopharmacology.
Chemical Structure[edit]
5-MAPDB is characterized by the presence of a benzodioxole ring, which is a common feature in many psychoactive substances. The chemical structure of 5-MAPDB includes a pentyl chain attached to the nitrogen atom, which differentiates it from other similar compounds. This structural modification is believed to influence its pharmacological activity.
Pharmacology[edit]
5-MAPDB acts primarily as a serotonin releasing agent, similar to other compounds in the substituted amphetamines class. It is known to increase the levels of serotonin in the synaptic cleft, leading to enhanced mood and altered perception. The compound may also have effects on other neurotransmitter systems, including dopamine and norepinephrine.
Effects[edit]
The effects of 5-MAPDB are similar to those of other entactogens, producing feelings of empathy, euphoria, and emotional closeness. Users may experience altered sensory perception and increased sociability. However, the safety profile and potential for neurotoxicity of 5-MAPDB are not well understood, and it is not approved for medical use.
Legal Status[edit]
The legal status of 5-MAPDB varies by country. In some jurisdictions, it is classified as a controlled substance due to its structural similarity to other illegal drugs. Researchers must often obtain special licenses to study its effects in a laboratory setting.
Related Compounds[edit]
5-MAPDB is part of a larger group of compounds known as substituted benzodioxoles. Other related compounds include MDA, MDMA, and MDEA, each with varying effects and legal statuses.
Research[edit]
Research on 5-MAPDB is limited, but it is of interest in the field of neuropsychopharmacology for its potential to provide insights into the mechanisms of action of entactogenic drugs. Studies often focus on its binding affinity to various receptor sites and its effects on neurotransmitter release.
See Also[edit]
Related pages[edit]
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
Medical weight loss NYC | Affordable GLP-1 injections NYC | Budget GLP-1 weight loss shots Philadelphia | New Jersey medical weight loss | NYC medical weight loss | Philadelphia medical weight loss | Sleep clinic NYC | W8MD's Philadelphia GLP-1 doctor | Weight loss prescriptions NYC
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian